<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02725307</url>
  </required_header>
  <id_info>
    <org_study_id>R15107</org_study_id>
    <nct_id>NCT02725307</nct_id>
  </id_info>
  <brief_title>Non-invasive Peri- and Postoperative Monitoring of Femoral Artery Balloon Angioplasty</brief_title>
  <official_title>Non-invasive Peri- and Postoperative Monitoring of Femoral Artery Balloon Angioplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tampere University of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Tampere</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates a novel noninvasive method to dynamically monitor the effect of
      percutaneous transluminal angioplasty on arterial pulse wave
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with stenosis of superficial femoral artery referred for percutaneous transluminal
      angioplasty are monitored before, during and after the procedure and pulse wave analysis is
      conducted.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">May 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pulse wave change from baseline during PTA</measure>
    <time_frame>1 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulse wave characteristics after PTA</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Noninvasive pulse wave analysis sensor, ECG-sensor</intervention_name>
    <description>Noninvasive pulse wave sensors and ECG-sensors are attached</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Volunteer patients with diagnosed peripheral atherosclerotic disease referred for femoral
        artery percutaneous transluminal angioplastu.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The patient has been clinically examined at policlinic of vascular surgery

          2. The patient has undergone measurement of ankle-brachial index (ABI) and toe-brachial
             index (TBI) at policlinic of vascular surgery and exhibits abnormal ABI&lt;0.9 or ABI&gt;1.3

          3. The patient is considered to have an indication for vascular procedure (critical limb
             ischemia, intermittent claudication)

          4. The patient has been examined with magnetic resonance imaging (MRA)

          5. The patient has been considered a candidate for superficial femoral artery
             percutaneous transluminal balloon angioplasty (PTA) and/or stenting

        Exclusion Criteria:

          1. Pacemaker

          2. Measurement disturbs or risks the subject's treatment process

        Withdrawal:

          1. Emergency cases

          2. By subject's denial

          3. Inability to detect signals -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Niku Oksala, Assoc. Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tampere</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <zip>33100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2016</study_first_submitted>
  <study_first_submitted_qc>March 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2016</study_first_posted>
  <last_update_submitted>May 3, 2017</last_update_submitted>
  <last_update_submitted_qc>May 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tampere University Hospital</investigator_affiliation>
    <investigator_full_name>Niku Oksala</investigator_full_name>
    <investigator_title>Associate Professor (Tenure track)</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

